News

CHICAGO, IL – July 13, 2023 – Sheridan is pleased to announce the successful closing of Sheridan Capital Partners Fund III, L.P. (together with its parallel fund, “Fund III” or the “Fund”), at the hard cap with $575 million of total capital commitments.

The Fund was oversubscribed, significantly exceeding its target of $450 million despite the challenging fundraising environment. Sheridan Capital Partners (“Sheridan”) is focused on making investments in lower middle market companies in recession resistant, non-discretionary markets within the healthcare industry. The Fund will continue Sheridan’s strategy of making control investments in North American founder-owned businesses with $3-20 million of EBITDA. Sheridan is led by Partners Jonathan Lewis and Sean Dempsey.

“We deeply value the support we received from our existing investor base for this fundraise, as well as the new strategic partnerships we have created in Fund III, which further diversify our high-quality group of insurance companies, consultants, pensions, family offices, sovereign wealth funds and fund-of-funds across North America, Europe and the Middle East,” said Jonathan Lewis, Partner at Sheridan.

“It has been a great partnership working with Sixpoint on another successful fundraise and we’d like to thank them for their continued commitment and strategic advice,” stated Sean Dempsey, Partner at Sheridan. “We’d also like to thank our limited partners for their critical role in closing Fund III at $575 million. We are very excited about the next phase of growth for our firm as we continue to expand both our team and presence in lower middle market healthcare.”